Monday, 13 March 2017

Global Water Intelligence (GWI) Publishes Comprehensive Article with Comments from BioLargo CEO Dennis P. Calvert and Industry Experts on Ballast Water Treatment Challenges and Solutions


BioLargo was fortunate to participate in a recent interview that contributed to a comprehensive market synopsis on the Ballast Water Treatment industry, published in the February 2017 issue of Global Water Intelligence. GWI is widely known as the publication leader in high-value business information for the global water industry.

Dennis Calvert, CEO of BioLargo, Inc. commented about the company’s participation in the article, “BioLargo was honored to be included as a ‘challenger’ and obviously an up-and-coming thought-leader for this highly charged industry segment, as stakeholders around the world evaluate this emerging market and chart a course ahead. We are watching closely as the market opportunity takes shape.”

A brief synopsis of the article and an assortment of Calvert’s comments can be found below.

In order to halt the worldwide spread of invasive or harmful marine species, the International Maritime Organization (IMO) passed the Convention for the Control and Management of Ships’ Ballast Water and Sediments (BWM), requiring more than 65,000 ships over 400 gross tons to adopt approved ballast water management plans. For most ships this will require the installation of a type-approved ballast water treatment system. The convention, adopted in 2004, was plagued with delays for years, but now is finally “setting sail” as reported in a recent feature article published by Global Water Intelligence.

The article titled “Starting the Voyage of a Lifetime”, published in the February 2017 issue of Global Water Intelligence, reads, “The long overdue ratification of the 2004 IMO ballast water management convention is expected to unleash a flood of orders for treatment systems,” and then asks, “How will the technology market shape up?” Several expert industry members are interviewed throughout the article, and the overarching sentiment of the piece is that, with an estimated $50 billion at stake for ballast water treatment systems, suppliers, ship operators, and investors will be well-served by developing a thorough understanding of the challenges and potential solutions inherent to ballast water management.

The fundamental challenges facing new ballast water treatment systems are capital and operating costs, size and power requirements, efficacy, and residual toxicity. US Coast Guard approval is also crucial because as Don Stephen, VP Product Management at De Nora was quoted, “Very few people (operators) would take the chance of procuring a system that is unable to be USCG approved because almost certainly there would be a chance of the ship traveling into US waters at some point.”

Ultraviolet and electro-chlorination are today’s leading systems, but both have issues that must be overcome. For one, chlorination-based technologies do not typically treat water upon discharge of ballast water, but rather treat water only during uptake. UV systems, on the other hand, treat at both ends. Young Chang, CEO of C&C Panasia, explains that though this is not currently an issue, the USCG and Marine Environmental Protection Committee have been investigating whether all systems should treat on discharge as well as uptake, following the discovery of some organisms hidden in sediment may not be killed. “It is highly possible in the next few years there will be new requirements saying that all types of treatment systems must treat on deballasting,”  Chang commented. “If that happens, non-UV based technologies will have a tough time to accommodate that and the system may get more complicated.” Another issue with chlorine-based systems is that their active chemicals must be removed from discharge water, meaning a neutralizer injection is required during deballasting to avoid discharge of harmful chemicals.

UV-based systems are not without their problems, however. While chlorine-based systems are capable of killing waterborne microorganisms, UV systems inactivate microbes by making them unable to reproduce, but leave them alive nonetheless, conflicting with the language of the IMO convention regarding discharged organisms.

In order to meet the USCG requirements, substantial power increases in UV systems were necessary to sufficiently neutralize organism activity. Tore Andersen, CEO of Optimarin, explained to GWI how the company was able to overcome this potential challenge. “We used our high power capacity – the biggest difference between Optimarin and other UV makers is our very strong UV lamp.”

Dennis Calvert, the CEO of BioLargo, Inc. (OTC: BLGO), singled out what appears to be one of the most critical problems of all when he shared his thoughts with GWI, “The larger issue is power availability on the ships. Energy efficiency for BWTS will be a key prerequisite to advance in the market… they require large amounts of energy to operate and may require more energy than what ships can currently supply.”  He continued, “There are very few examples where older ships have sufficient excess power for these new BWTS”. According to Calvert, this problem doesn’t afflict all ships, as he was quoted, “Some ships will however not have this problem, such as LNG with regasification compressors and large container ships with reefer power available.”  It’s clear that for those ships with stringent power supplies, energy efficiency of ballast water treatment systems is a key factor dictating their adoption.

BioLargo’s AOS System is billed as the low energy solution to the ballast water treatment challenge, and is targeting entry into the ballast water market by 2019. “While we have some scale-up work to do to meet the volume requirements for the maritime industry, we believe our value proposition is unique, and the industry clearly needs a low energy solution like ours,” Calvert reported to GWI.

With new the new regulations coming into force in September 2017, the shipping industry faces an intense challenge working to conform to the new operating procedures.  The technology market will no doubt be exciting to watch. The GWI article wrapped up with Calvert’s comments, “We believe the systems that are flexible, modular in design, and remain low cost and offer low energy solutions while meeting volume rates will take the lead … the market prescribed by these regulations is so large in scope that an army of companies will be busy for the next two decades.”

BioLargo is positioned to make an impact in the Ballast Water Treatment Industry as it advances its technology, builds strategic alliances, and supports its leading-edge science with talent and resources. A series of important articles published on this blog chronicle the company's milestones.

Wednesday, 8 March 2017

BioLargo CEO, Dennis Calvert: Interview at Uptick Newswire to discuss commercial progress



Dennis Calvert, CEO for BioLargo, Inc. (BLGO), returns to the show with Jasyn Blair and they discuss updates to their Odor & Wound Care lines and getting these products to market.  


Tuesday, 7 February 2017

BioLargo’s Advanced Oxidation System (AOS) Poised to Impact $862 Billion Global Water Market


Goldman Sachs calls water “the petroleum
for the next century” adding, “investors who
know how to play the infrastructure boom
will reap huge rewards.”

Test results show that the AOS achieves
unprecedented rates of disinfection, and eliminates
infectious biological pathogens such as Salmonella
enterica, Listeria monocytogenes and E. coli.

BioLargo continues its mission to Make Life Better.  

Biolargo Signs Veteran Water Industry Executive Mark Lambert as Strategic Advisor


BioLargo, Inc. (OTCQB: BLGO) announced that Mark Lambert had joined its team as a “strategic advisor” to help develop and refine the company’s commercialization plan for its break-through Advanced Oxidation System within the water industry. Mr. Lambert has over 25 years of experience as a senior level executive with extensive experience in the water, renewable energy and environmental services industries and has a strong track record of success in the management of successful organizations. Mr. Lambert’s expertise includes P&L and operations management, sales and marketing management, mergers and acquisitions, strategic planning, growth capital and transactional support.

Most recently Mr. Lambert served as Chief Executive Officer of IDE Americas Inc., a world leader in water treatment solutions specializing in the development, engineering, construction and operation of enhanced desalination and industrial water treatment plants. Mr. Lambert was responsible for all IDE activities in the Americas, including project delivery methods such as Engineering Procurement & Construction, Build & Operate, and Build Own Operate & Transfer. In addition to desalination, under Mr. Lambert’s tenure as CEO IDE Americas activities included industrial wastewater treatment in oil and gas, power generation, and mining.

Prior to IDE Americas, Mr. Lambert was Chief Operating Officer of Test America, a leading environmental testing firm focusing on clients in the municipal and industrial market sectors. In that role, Mr. Lambert was responsible for the P&L management of the analytical testing division with annual revenue of $350 million and 2,500 employees. Mr. Lambert has also held various senior management positions, including at American Water, U.S. Filter (Siemens) Corporation, Culligan, and Imperial Chemical Industries.  Mr. Lambert is actively involved in the water and environmental community, including the American Water Works Association (AWWA) and the Water Quality Association, and has served on several AWWA and WQA steering committees including the Point of Use committee and was a founding member of the WQA World Assembly. Mr. Lambert is a certified EPA “CUPPS” trainer for small community water agencies. Mr. Lambert received a BS in Chemical Engineering from U.C. Berkeley and an MBA from Golden Gate University.

BioLargo’s president Dennis P. Calvert commented, “We are honored that Mark has chosen to work with us and to help guide our company to the next level. We believe his extensive experience, knowledge and relationships in the water industry will help propel BioLargo’s technologies forward to commercial success.”

Mr. Lambert commented, “BioLargo’s Advanced Oxidation System (AOS) represents a breakthrough in the cost-effective treatment of difficult water and wastewater streams for both municipal and industrial applications. I look forward to working with the team at BioLargo in positioning this advanced technology for commercial success”

About BioLargo, Inc. 
BioLargo, Inc. (BLGO) makes life better by delivering sustainable technology-based products that help solve some of the most widespread problems threatening the world's supply of water, food, agriculture, healthcare and energy. More information can be found about the company and its subsidiaries at www.BioLargo.com. Its subsidiary BioLargo Water, Inc. (www.BioLargoWater.com) showcases the Advanced Oxidation Systems, including its AOS Filter -- a product in development specifically designed to eliminate common, troublesome, and dangerous (toxic) contaminants in water in a fraction of the time and cost of current technologies. It is the winner of the Technology Star award by New Technology Magazine for its breakthrough innovation for the oil industry and is named the Technology Innovation Leader in the water treatment market by Frost & Sullivan. BioLargo also owns a 50% interest in the Isan System, which was honored with a "Top 50 Water Company for the 21st Century" award by the Artemis Project now being commercialized under a license to Clarion Water, Inc. BioLargo's subsidiary Odor-No-More Inc., features award-winning products serving the pet, equine, military supply and consumer markets, including the Nature's Best Solution® and Deodorall® brands (www.OdorNoMore.com). BioLargo's subsidiary Clyra Medical Technologies, Inc. (www.ClyraMedical.com) focuses on advanced wound care management.

Safe Harbor Statement
The statements contained herein, which are not historical, are forward-looking statements that are subject to risks and uncertainties that could cause actual results to differ materially from those expressed in the forward-looking statements, including, but not limited to, the risks and uncertainties included in BioLargo's current and future filings with the Securities and Exchange Commission, including those set forth in BioLargo's Annual Report on Form 10-K.

Tuesday, 24 January 2017

Biolargo Hatches Plan to Help Poultry Industry Make Clean Farms, Healthy Chickens, Safer Food and More Profit


The poultry industry is big business, but also faces big challenges. Since 1992, chicken has outpaced beef in per capita sales in the U.S., and during 2016, wholesale poultry sales were $60 billion. Despite this progress, a barrier to continued growth in this sector is pathogen control and other poultry health challenges that have demonstrated their potential to impact sales negatively.

Avian Flu (HPAI) outbreaks in the U.S. have impacted exports significantly, according to
Nan-Dirk Mulder, senior global animal protein analyst, Rabobank: "There is weak demand for U.S. broiler exports, which may be down 10 percent due to the trade restrictions that have resulted from the HPAI outbreaks."

Improving the health and safety of poultry is clearly of great importance to industry because it can help shore up sales and reduce potentially large losses at a time when margins are struggling well below 5%.

The economics of modern poultry production dictate the crowded nature of poultry coops or cages. In turn, crowding makes it difficult to manage cleanliness and pathogen transmission. Producers are doing their best with the limited arsenal of solutions available to them today, but they are still searching for novel technologies to ensure maximum health for their animals, maximum quality and quantity for their products, and minimum environmental impacts.

Disease Management in Poultry

In the spring of 2015, the second largest egg producer in the US lost 4 million laying hens to avian flu, illustrating a serious need for stronger disease management practices in the poultry industry. The economic effects of this virus are profound - in 2015 a total of 42 million chickens and turkeys were killed or culled because of avian influenza. The Cargill turkey product recall in 2011, where 36 million pounds of ground turkey were recalled due to Salmonella contamination, is another stark reminder of the importance of strong disinfection practices both in poultry production as well as processing.

Other diseases affecting the profitability of poultry production include cellulitis, a condition caused by the infection of cuts and scratches on birds by E. coli, which results in an estimated $12 million in annual condemnation losses in the U.S, as well as Coccidiosis, Coryza, Marek's Disease, Newcastle Disease, Mycoplasma, and Salmonellosis.

In the face of these problems, poultry and egg producers have historically turned to antibiotics and extensive use of chemical cleaners. However, in light of rising antimicrobial resistance, producers are being pressured to curtail prophylactic antibiotic use. Recent studies have isolated several strains of antibiotic-resistant bacteria in production chickens, illustrating the need for poultry producers to take steps to help stem the tide of antibiotic-resistant pathogens that threaten both animal and human health. Disease prevention in the poultry industry is a battle fought on many fronts, with water and waste management being major areas of concern. It is of utmost importance for water, at all stages in production and processing, to be free of bacterial and chemical contaminants. Existing water treatment technologies, such as the commonly employed chlorine dioxide (ClO­2­), fall short in several aspects, from unpleasant or toxic fumes, corrosion, pH sensitivity, and high operating costs. There is a clear market need for an effective, safe, and economically sustainable clean water technology to meet the challenges of water treatment in the poultry industry.

Poultry production, like any livestock industry, also produces a large quantity of organic waste, particularly manure. Ask any poultry worker, and they will attest to the powerful and unpleasant odors that this waste generates. A significant contributor to this effect is ammonia, which is produced in abundance by waste in poultry facilities. In addition to being unpalatable, ammonia accumulation has been shown to negatively impact the health of production chickens, emphasizing the importance of managing this and other odor-causing compounds in poultry production facilities.

BioLargo Solutions for Healthy Water, Healthy Animals, Healthy Food
Novel food and water safety technologies developed by BioLargo, Inc. (BLGO) can help alleviate many of the issues associated with crowded poultry production and processing sites, including disease management, sanitation, and odor control. All BioLargo platforms use the power of free iodine, a safe, long-studied disinfectant not associated with the development of antibiotic resistance in bacteria.

BioLargo's sustainable technologies have not gone unnoticed. The company reports it was recently awarded a research grant by the Metropolitan Water District (MWD) of Southern California, as part of their Innovation Conservation Program. The MWD, whose mission is to deliver high-quality water to Southern California while minimizing environmental impacts, is one of the nation's leading innovators in water conservation. MWD has awarded BioLargo this funding to evaluate its advanced clean water solution, the Advanced Oxidation System (AOS), for use in California's poultry and food processing sector. This award is the first from MWD and the first US-based grant awarded to BioLargo, with all its prior awards having come from Canada. It is the 31st research grant awarded to BioLargo and its technical collaborators to help advance the AOS to commercialization. The company reports that it has a number of research projects moving ahead to validate the AOS for use in well-water treatment for livestock production, animal health improvements from iodine drinking water, and process water recycling. BioLargo has recently begun working with the Alberta Chicken Producers association and commercial poultry producers. It has also recently become a member of North American Meat Institute.

To further boost commercialization of the AOS, BioLargo recently developed a relationship with Carollo Engineering, arguably the top water-related engineering firm in the US, to conduct verification analysis on BioLargo's technology. Dennis Calvert, CEO of BioLargo, commented, "Carollo will be providing independent third party oversight of some initial demonstration testing starting in February 2017."

This comes on the heels of news reported last month that BioLargo had developed a working relationship with Chicago Bridge & Iron (CB&I) to pursue mutual business opportunities and work towards larger industrial scale applications that can serve BioLargo and CB&I clients. CB&I is a world-leading engineering, procurement, fabrication, and construction company, and a provider of environmental and infrastructure services. CB&I has significant interests in environmental remediation, and has numerous clients whose challenges could be met with BioLargo's patented technologies. 

BioLargo's Lowest Cost, Highest Impact AOS Water Treatment Solution 
BioLargo, Inc.'s Advanced Oxidation System, or AOS, is a state-of-the-art water treatment platform that uses three simple ingredients: iodine chemistry, cutting-edge water filtration materials, and electrolysis, to achieve outstanding water disinfection and decontamination results. Researchers have found the AOS to be effective against Salmonella, Listeria, and E. coli, reducing bacterial values exceeding 6 logs (99.9999%) in highly contaminated water. This performance is roughly 100x greater than the best-in-class industry standard for poultry water disinfection, chlorine dioxide (ClO2). Researchers call the results "unprecedented". The AOS is also incredibly energy-efficient, estimated to consume is less than 1/20th the energy of UV disinfection, electro-chlorination, or ozonation systems. Dennis Calvert, BioLargo CEO says, "The AOS Filter in its Alpha configuration was specifically designed for deployment in the agricultural and livestock industries."



Isan System to Maintain Water Sanitation, Prevent Spread of Disease, and Reduce Airborne Wastes
AOS is not the only BioLargo technology that may impact the poultry industry. BioLargo's Isan System is an efficient, low-cost, reliable aqueous iodine delivery system, and already approved by the EPA for use in poultry drinking water. The Isan provides residual iodine for livestock production water, enabling persistent, long-lasting disinfection for that water as it is delivered to the animals. Featuring full automation, the Isan is a set-it-and-forget-it water treatment solution, and allows effective and cost-efficient water disinfection with minimal labor requirements. The Isan produces pure and accurate doses of iodine, a safe and long-understood disinfectant not associated with the development of any bacterial resistance - an important fact in a time when antimicrobial resistance is of the utmost concern. Iodine is also effective at a broader range of pH than chlorine-based solutions, meaning less labor is required to monitor and maintain the pH of water dosed by the Isan, and there is little chance of treatment failure due to pH fluctuations. Iodine is effective against a vast range of bacteria, viruses, and fungi, making it an ideal disinfectant to defend against the diverse pathogens relevant to the poultry industry.

Iodine, such as that used in the Isan system, has other benefits other than making clean water. Iodine has been shown to cause increased weight gain in some poultry, as well as negate some of the negative effects of bromine consumption in chickens. The beneficial effects of iodine in feed water are currently under additional study in a research collaboration between BioLargo and University of Alberta scientists. The study focuses on the effect of iodine in drinking water on the health of chicken guts and the composition of bacteria that live there, which has in recent years come to light as an important health determinant in all animals.

The Isan system is ideal for disinfecting large amounts of feed water, and is compatible with misting or spraying systems, providing a surface and air disinfection solution perfect for poultry production facilities. Iodine misted by an Isan system may be useful to reduce the incidence of topical infections such as cellulitis, a condition caused by scratches infected with E. coli, which iodine has well-documented efficacy against. Since cellulitis is a cause of meat condemnation and is estimated to cause upwards of $12 million in losses in the US alone each year, Isan implementation could save producers significant costs in this area alone. This is an area that is targeted for further study. 

CupriDyne Clean to Reduce Odor and Improve Air Quality 
In addition to AOS and Isan, BioLargo's CupriDyne Clean provides safe, gentle, and effective odor control solutions for industry. The FDA considers all components of CupriDyne Clean to be GRAS (generally recognized as safe) for consumption by humans and animals. It works by eliminating odor-causing chemicals (volatile organic compounds) rather than masking them with fragrances. CupriDyne Clean can improve air quality in poultry production facilities. CupriDyne clean has been shown to be effective in eliminating ammonia, a major contributor to unpleasant odors in livestock production and a source of health problems for livestock animals.

CupriDyne Clean is eco-friendly, non-toxic, and non-sensitizing, making it suitable for busy industrial settings where workers are present. CupriDyne Clean is also an effective stain remover and all-surface wash, and combined with its dramatic odor control, makes the perfect product to maintain a healthier, more productive facility.

Potential Beneficiaries of BioLargo Poultry Solutions 
Disruptive products commonly face challenging barriers to market entry (e.g. regulatory hurdles, incumbent advantage), and one would expect BioLargo's technologies to be no different. As BioLargo's superior products find their way to market, major poultry producers that stand to benefit from BioLargo's poultry solutions are:

  •  Tyson Foods, Inc. (TSN), processed 33.41 million broilers at an average live weight of 5.75 pounds to produce 175.6 million RTC pounds of chicken on an average weekly basis in 2015. 
  • U.S. broiler producer, Pilgrim's Pride Corporation (PPC), processed 28.85 million broilers weekly at an average live weight of 5.71 pounds to produce 141.67 million pounds of chicken. 
  • Sanderson Farms, Inc. (SAFM) 
  • Cal-Maine Foods, Inc. (CALM), is the largest egg producer. 
  • BRF S. A. (BRFS) is a leading producer of poultry and pork in Brazil.
  • $19 billion Hormel Foods Corporation (HRL) provides a diverse array of meat products including numerous poultry products. 
  • $17 billion Conagra Brands, Inc. (CAG) 

With its high impact, low cost clean water and air solutions, poultry industry operators should soon be flocking to BioLargo to help them achieve increased profits and decreased risk across the board. 

About BioLargo, Inc. 
BioLargo "makes life better" by delivering technology-based products that help solve some of the world's most important problems that threaten water, food, agriculture, healthcare and energy. More information can be found about the company and its subsidiaries at www.BioLargo.com. The subsidiary BioLargo Water, Inc. (www.BioLargoWater.com) showcases the Advanced Oxidation System (AOS), a product designed to eliminate common, troublesome, and toxic contaminants in water in a fraction of the time and at a fraction of the cost of current technologies. It is the winner of the Technology Star award by New Technology Magazine for its breakthrough innovation for the oil industry. BioLargo also owns a 50% interest in the Isan System, which was honored with a "Top 50 Water Company for the 21st Century" award by the Artemis Project. The subsidiary Odor-No-More Inc., features award-winning products serving the pet, equine, and consumer markets, including the Nature's Best Solution(R) and Deodorall(R) brands. (www.OdorNoMore.com). The subsidiary Clyra Medical Technologies, Inc. (www.ClyraMedical.com), focuses on advanced wound care management and is preparing to make FDA 510(k) applications in 2017.

Tuesday, 20 December 2016

widget